Panacea Innovation Ltd - 30 Jan 2025 SCHEDULE 13G Report for Atara Biotherapeutics, Inc. Common Stock, par value $0.0001 per share (ATRA)

Filing Manager
Panacea Innovation Ltd
Reporting Manager
Panacea Venture Healthcare Fund II, L.P.
Security
Atara Biotherapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
ATRA
Shares outstanding
5,789,474 shares
Disclosed Ownership
550,000 shares
Ownership
9.5%
Form type
SCHEDULE 13G
Filing time
06 Feb 2025, 18:34:13 UTC
Date of event
30 Jan 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Panacea Venture Healthcare Fund II, L.P. 9.5% 550,000 0 550,000 By: Panacea Venture Healthcare Fund II GP Company, Ltd., its general partner, By: Panacea Innovation Limited, its sole owner, /s/ James Huang James Huang, Founding Managing Partner
Panacea Venture Healthcare Fund II GP Company, Ltd. 9.5% 550,000 0 550,000 By: Panacea Innovation Limited, its sole owner, /s/ James Huang James Huang, Founding Managing Partner
Panacea Innovation Limited 9.5% 550,000 0 550,000 /s/ James Huang James Huang, Founding Managing Partner
James Huang 9.5% 550,000 0 550,000 /s/ James Huang James Huang